A Phase 3, single arm, clinical trial to the study the contraceptive efficacy and safety of the MK-8342B (etonogestrel+17 estradiol) vaginal ring in health women 18 years of age and older, at risk for pregnancy.
Contraceptive Vaginal Ring
Sponsor: Merck Sharp & Dohme Corp.
Enrolling: Female Patients Only
Study Length: 13 Months
Clinic Visits: 7
IRB Number: AAAP4000
U.S. Govt. ID: NCT02524288
Contact: Paula Castano: 646-317-4754 / fpresearch@cumc.columbia.edu
Additional Study Information: Hormonal Vaginal Ring for Contraception
This study is closed
Investigator
Paula Castano, MD, MPH
Do You Qualify?
Are you 18 years of age or older? Yes No
Are you currently sexually active and seeking contraception? Yes No
Are you willing to use a hormonal vaginal ring as your primary method of contraception? Yes No
Submit
Cancel
You may be eligible for this study

Place Holder



Cancel
For more information, please contact:
Paula Castano
fpresearch@cumc.columbia.edu
646-317-4754
This website uses cookies as well as similar tools and technologies to understand visitors’ experiences. By continuing to use this website, you consent to Columbia University’s usage of cookies and similar technologies, in accordance with the Columbia University Website Cookie Notice.
I AGREE